Press

Harro Höfliger and LEON collaborate to bring the innovative NANOus LNP-encapsulation device to market for rapid, large-scale prophylactic vaccine manufacturing

The system fills 43,500 capsules per hour. It is also available as a containment variant.

Fifth location of the mechanical engineering company specializing in pharmaceutical and medical markets. Jobs of all Widmann employees secure.

The second laboratory allows Harro Höfliger to provide additional analytical methods - reducing mechanical engineering process risks even before the design phase begins.

Harro Höfliger has become a shareholder in the start-up company DiHeSys (Digital Health Systems GmbH). Together they want to help shape the future of personalized medicine.

Fusion of equals

Vaxxas and Harro Höfliger have entered into a strategic cooperation for the industrial-scale production of new vaccine technology.